Stroke

What Is a Stroke?

A stroke occurs when blood flow to part of the brain is disrupted, depriving brain cells of the oxygen and nutrients they need to survive, and the two main types, ischemic and hemorrhagic, arise through fundamentally different mechanisms.¹

Most strokes are ischemic, occurring when a blood clot or other particle blocks a blood vessel supplying the brain, sometimes due to fatty plaque buildup narrowing the vessel over time.¹

Hemorrhagic stroke, by contrast, occurs when a blood vessel within the brain leaks or ruptures, and the resulting blood puts damaging pressure on surrounding brain cells, with conditions such as high blood pressure and aneurysms representing common underlying causes.¹

A hemorrhagic stroke happens when an artery in the brain leaks blood or ruptures, and the leaked blood puts too much pressure on brain cells, which damages them.
Centers for Disease Control and Prevention

Symptoms

Sudden onset of specific neurological symptoms, including facial drooping, arm weakness, and difficulty speaking, represents the classic presentation of stroke, prompting the widely used reminder to act fast when these signs appear.

Certain symptoms occur significantly more often with hemorrhagic stroke compared to ischemic stroke, including coma, neck stiffness, vomiting, altered consciousness, severe headache, fainting, seizure, and vertigo.²

Because symptom overlap between stroke types can make bedside diagnosis challenging, rapid brain imaging remains essential for accurately distinguishing ischemic from hemorrhagic stroke and guiding appropriate, time sensitive treatment decisions.²

Causes

Ischemic stroke triggers a complex cascade of cellular events, including energy depletion within affected brain cells, disrupted ion balance, oxidative stress, inflammation, programmed cell death, breakdown of the blood brain barrier, and brain swelling.³

Hemorrhagic stroke causes damage through two distinct mechanisms, direct physical pressure from the pooled blood itself, along with additional injury caused by toxic breakdown products released from the blood clot over the following hours and days.³

Atrial fibrillation, an irregular heart rhythm, represents a particularly important cause of ischemic stroke, since blood clots can form within the heart’s left atrial appendage and subsequently travel to the brain, causing what is known as a cardioembolic stroke.⁴

Risk Factors

Atrial fibrillation stands out as a significant, independent stroke risk factor, increasing ischemic stroke risk roughly fivefold and present in an estimated fifteen to twenty one percent of stroke patients overall.⁴

Additional risk factors for stroke, and specifically for bleeding complications during stroke treatment, include advanced age, male sex, obesity, diabetes, uncontrolled high blood pressure, and combined use of multiple antiplatelet medications.⁵

Congestive heart failure and evidence of prior small vessel brain injury also raise treatment related risk, illustrating how a patient’s overall cardiovascular health profile meaningfully influences stroke risk and treatment safety alike.⁵

Complications

Because both ischemic and hemorrhagic stroke can rapidly damage brain tissue, the specific location and extent of injury determine which functions, including movement, speech, and cognition, are ultimately affected.

For patients receiving clot dissolving medication, symptomatic bleeding represents a serious potential complication, with risk influenced by numerous individual patient factors present at the time of treatment.⁵

Recurrent stroke represents an ongoing risk for survivors, particularly among patients with atrial fibrillation who are not receiving appropriate preventive anticoagulation therapy.⁴

Treatment

For eligible patients with ischemic stroke, restoring blood flow through clot dissolving medication or a procedure called thrombectomy represents the primary treatment approach, with alteplase remaining the only thrombolytic medication currently approved for this purpose in the United States.¹

Endovascular thrombectomy, a procedure that mechanically removes a blood clot from a large brain artery, has demonstrated both safety and effectiveness for appropriately selected patients with significant vessel blockage.¹

For stroke prevention in patients with atrial fibrillation, oral anticoagulant medication provides a substantial forty percent reduction in recurrent stroke risk compared to antiplatelet therapy alone, with newer anticoagulant medications offering comparable effectiveness alongside a reduced risk of serious bleeding compared to older options.⁴

Prevention

For people with atrial fibrillation, consistent use of appropriate anticoagulant therapy represents one of the most effective available strategies for preventing stroke, given the substantially elevated risk this heart rhythm condition carries.⁴

Managing modifiable cardiovascular risk factors, including blood pressure, diabetes, and obesity, plays an important role in reducing overall stroke risk across both major stroke types.⁵

Rapid recognition of stroke symptoms and prompt emergency medical evaluation remain essential, since the effectiveness of many stroke treatments depends heavily on how quickly they can be administered following symptom onset.

Why Visual Communication Matters for Stroke

Explaining how two fundamentally different mechanisms, a blocked vessel versus a ruptured one, can both be called stroke requires visuals that clearly distinguish these processes and the urgent, time sensitive treatments each requires.

Pharmaceutical companies, neurology and cardiology practices, and public health organizations rely on clear illustration and animation to explain stroke biology and support timely recognition and treatment.

• Illustrating the differences between ischemic and hemorrhagic stroke mechanisms
• Animating how atrial fibrillation leads to cardioembolic stroke
• Explaining thrombolytic therapy and endovascular thrombectomy procedures
• Visualizing anticoagulant mechanisms for stroke prevention
• Supporting public health education on rapid stroke symptom recognition
• Creating training materials for neurology, cardiology, and emergency medicine clinicians

How Biotic Artlab Supports Stroke Communication

We work with pharmaceutical companies, neurology and cardiology practices, and public health organizations to create accurate, urgent, and clear visuals that make stroke and its treatment easier to understand.

• Custom 3D animations comparing ischemic and hemorrhagic stroke mechanisms
• Detailed illustrations of thrombectomy and thrombolytic treatment procedures
• Mechanism of action animations for anticoagulant stroke prevention therapy
• Patient facing materials on rapid symptom recognition and emergency response
• Clinical training content for neurology, cardiology, and emergency medicine teams
• Conference presentations and public health materials for stroke awareness campaigns

Frequently Asked Questions

What is the difference between ischemic and hemorrhagic stroke?

Ischemic stroke results from a blocked blood vessel, while hemorrhagic stroke results from a ruptured or leaking blood vessel within the brain.¹

What causes a cardioembolic stroke?

Atrial fibrillation can cause blood clots to form in the heart and travel to the brain, causing a cardioembolic ischemic stroke.⁴

What is the main treatment for ischemic stroke?

Restoring blood flow through clot dissolving medication or mechanical thrombectomy represents the primary treatment for eligible patients.¹

How does atrial fibrillation affect stroke risk?

Atrial fibrillation increases ischemic stroke risk roughly fivefold and is present in a significant proportion of stroke patients.⁴

Can stroke be prevented?

Yes, managing cardiovascular risk factors and using appropriate anticoagulation for atrial fibrillation both meaningfully reduce stroke risk.⁴

Why does speed matter in stroke treatment?

Many stroke treatments are time sensitive, with effectiveness depending heavily on how quickly they are administered after symptom onset.

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to stroke or neurovascular health, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. Centers for Disease Control and Prevention. About Stroke.
2. National Center for Biotechnology Information. Discrimination of Ischemic Versus Hemorrhagic Stroke Type by Presenting Symptoms or Signs.
3. National Center for Biotechnology Information. Epidemiology, Pathophysiology, and Current Treatment Strategies in Stroke.
4. National Center for Biotechnology Information. Ischemic Stroke Risk Factors in Patients With Atrial Fibrillation Treated With New Oral Anticoagulants.
5. National Center for Biotechnology Information. Safety of Thrombolysis in Acute Ischemic Stroke, a Review of Complications, Risk Factors, and Newer Technologies.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.